Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Catarina Pinto

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Journal of Thoracic Disease|July 3, 2013
Sexuality and breast cancer: prime time for young patientsAna Catarina Pinto
Maturitas|October 22, 2011
Improving quality of life after breast cancer: dealing with symptomsAna Catarina Pinto, Evandro de Azambuja
Journal of Thoracic Disease|October 3, 2014
Breast cancer control in China: challenges and opportunities of the use of population-based routine data studiesAna Catarina Pinto, Rita Canário, Paula Fidalgo
Cancer Chemotherapy and Pharmacology|December 24, 2008
Ciprofloxacin sensitizes hormone-refractory prostate cancer cell lines to doxorubicin and docetaxel treatment on a schedule-dependent mannerAna Catarina Pinto, João Nuno Moreira, Sérgio Simões
The Prostate|July 8, 2010
Liposomal imatinib-mitoxantrone combination: formulation development and therapeutic evaluation in an animal model of prostate cancerAna Catarina Pinto, João Nuno Moreira, Sérgio Simões
Journal of Thoracic Disease|July 1, 2014
Fertility issues in young breast cancer patients: what women wantMatteo Lambertini, Ana Catarina Pinto, Lucia Del Mastro
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 6, 2022
Oromucosal products - Market landscape and innovative technologies: A reviewFrancisca Bastos, Ana Catarina Pinto, António Nunes, et al.
Breast Care (Basel, Switzerland)|January 14, 2014
How Long is Enough - Optimal Timing of Anti-HER2/neu Therapy in the Adjuvant Setting in Early Breast CancerAna Catarina Pinto, Evandro de Azambuja, Martine Piccart-Gebhart
Cancer Chemotherapy and Pharmacology|April 10, 2010
Schedule treatment design and quantitative in vitro evaluation of chemotherapeutic combinations for metastatic prostate cancer therapyAna Catarina Pinto, Susana Ângelo, João Nuno Moreira, et al.
Journal of Nanoscience and Nanotechnology|July 5, 2012
Development, characterization and in vitro evaluation of single or co-loaded imatinib mesylate liposomal formulationsAna Catarina Pinto, Susana Angelo, João Nuno Moreira, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of Thoracic Disease|July 3, 2013
Sexuality and breast cancer: prime time for young patientsAna Catarina Pinto
Maturitas|October 22, 2011
Improving quality of life after breast cancer: dealing with symptomsAna Catarina Pinto, Evandro de Azambuja
Journal of Thoracic Disease|October 3, 2014
Breast cancer control in China: challenges and opportunities of the use of population-based routine data studiesAna Catarina Pinto, Rita Canário, Paula Fidalgo
Cancer Chemotherapy and Pharmacology|December 24, 2008
Ciprofloxacin sensitizes hormone-refractory prostate cancer cell lines to doxorubicin and docetaxel treatment on a schedule-dependent mannerAna Catarina Pinto, João Nuno Moreira, Sérgio Simões
The Prostate|July 8, 2010
Liposomal imatinib-mitoxantrone combination: formulation development and therapeutic evaluation in an animal model of prostate cancerAna Catarina Pinto, João Nuno Moreira, Sérgio Simões
Journal of Thoracic Disease|July 1, 2014
Fertility issues in young breast cancer patients: what women wantMatteo Lambertini, Ana Catarina Pinto, Lucia Del Mastro
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 6, 2022
Oromucosal products - Market landscape and innovative technologies: A reviewFrancisca Bastos, Ana Catarina Pinto, António Nunes, et al.
Breast Care (Basel, Switzerland)|January 14, 2014
How Long is Enough - Optimal Timing of Anti-HER2/neu Therapy in the Adjuvant Setting in Early Breast CancerAna Catarina Pinto, Evandro de Azambuja, Martine Piccart-Gebhart
Cancer Chemotherapy and Pharmacology|April 10, 2010
Schedule treatment design and quantitative in vitro evaluation of chemotherapeutic combinations for metastatic prostate cancer therapyAna Catarina Pinto, Susana Ângelo, João Nuno Moreira, et al.
Journal of Nanoscience and Nanotechnology|July 5, 2012
Development, characterization and in vitro evaluation of single or co-loaded imatinib mesylate liposomal formulationsAna Catarina Pinto, Susana Angelo, João Nuno Moreira, et al.
Pageof 3